Brief: Hofseth Biocare ASA Says Significant New Investment Of NOK 144 Mln From Hofseth International Into HBC
13/12/2023 21:52
Dec 13 (Reuters) - Hofseth Biocare ASA HBC.OL :
* SIGNIFICANT NEW INVESTMENT OF NOK 144 MILLION FROM HOFSETH
INTERNATIONAL INTO HBC
* HBC WILL ISSUE A NEW CLASS OF PREFERENCE SHARES TO HOFSETH
INTERNATIONAL AT A SUBSCRIPTION PRICE OF NOK 9 PER B-SHARE
Source text for Eikon: ID:nGNE1lJx8C
Further company coverage: HBC.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering